Stay updated on CGT9486 Alone and With PLX3397 or Sunitinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the CGT9486 Alone and With PLX3397 or Sunitinib in Solid Tumors Clinical Trial page.

Latest updates to the CGT9486 Alone and With PLX3397 or Sunitinib in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.SummaryDifference0.1%
- Check12 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new pharmaceutical compounds like pexidartinib. Notably, previous mentions of gastrointestinal stromal tumors have been modified.SummaryDifference1%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check40 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.0%
- Check48 days agoChange DetectedThe web page has been updated to include new information about a clinical study involving CGT9486, including its purpose, treatment details, and eligibility criteria. Additionally, the page has removed some redundant content and error messages.SummaryDifference100%
Stay in the know with updates to CGT9486 Alone and With PLX3397 or Sunitinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CGT9486 Alone and With PLX3397 or Sunitinib in Solid Tumors Clinical Trial page.